Please login to the form below

Not currently logged in
Email:
Password:

Dr Olivier Danos joins TxCell scientific advisory board

He currently serves as cell and gene therapy SVP at Biogen

TxCell Dr Olivier DanosFrench biotechnology company TxCell has appointed Biogen's Dr Olivier Danos to its scientific advisory board.

Since 2014, Dr Danos has served as senior vice president of cell and gene therapy at Biogen, leading its research group to develop new technologies for gene transfer and genome engineering.

Before to taking up this role in 2011, Dr Danos was Kadmon Pharmaceutical's senior vice president for molecular science, synthetic biology and gene regulation, where he led the creation of its gene therapy and technology platforms.

He has also served as director of the Gene Therapy Consortium at University College London, scientific director of Généthon, and senior research director for France's National Centre for Scientific Research (CNRS).

Arnoud Foussat, chief scientific officer at TxCell, said: “Dr Olivier Danos has pioneered technologies of central importance in the field of gene therapy and genome editing.

“He is another significant addition to our scientific advisory board, which already includes leading experts in immunology, T-cell biology and chimeric antigen receptors.

“We are looking forward to their insights and advice on our current and future research and development programmes targeting severe chronic autoimmune and inflammatory diseases.”

1st September 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics